The quality validation results demonstrated that this is a robust and reliable dataset for exploring the transcriptomic changes in response to NRP1 knockdown across multiple claudin-low breast cancer cell lines on the level of genes or individual transcript variants. This evidence concerns the gene NRP1 and breast carcinoma.